Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Interventions for bone disease in children with chronic kidney disease.

Geary DF, Hodson EM, Craig JC.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD008327. doi: 10.1002/14651858.CD008327. Review. Update in: Cochrane Database Syst Rev. 2015;11:CD008327.

PMID:
20091666
2.

Interventions for metabolic bone disease in children with chronic kidney disease.

Hahn D, Hodson EM, Craig JC.

Cochrane Database Syst Rev. 2015 Nov 12;(11):CD008327. doi: 10.1002/14651858.CD008327.pub2. Review.

PMID:
26561037
3.

Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.

Navaneethan SD, Palmer SC, Vecchio M, Craig JC, Elder GJ, Strippoli GF.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006023. doi: 10.1002/14651858.CD006023.pub2. Review.

PMID:
21328279
4.

Vitamin D compounds for people with chronic kidney disease requiring dialysis.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005633. doi: 10.1002/14651858.CD005633.pub2. Review.

PMID:
19821349
5.

Vitamin D compounds for people with chronic kidney disease not requiring dialysis.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD008175. doi: 10.1002/14651858.CD008175. Review.

PMID:
19821446
6.

Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.

Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF.

Am J Kidney Dis. 2009 Oct;54(4):619-37. doi: 10.1053/j.ajkd.2009.06.004. Epub 2009 Aug 18. Review.

PMID:
19692157
7.

Interventions for preventing bone disease in kidney transplant recipients.

Palmer SC, McGregor DO, Strippoli GF.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005015. Review.

PMID:
17636784
8.

Dietary interventions for mineral and bone disorder in people with chronic kidney disease.

Liu Z, Su G, Guo X, Wu Y, Liu X, Zou C, Zhang L, Yang Q, Xu Y, Ma W.

Cochrane Database Syst Rev. 2015 Sep 16;(9):CD010350. doi: 10.1002/14651858.CD010350.pub2. Review.

PMID:
26376110
10.

Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.

Strippoli GF, Tong A, Palmer SC, Elder G, Craig JC.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006254. Review. Update in: Cochrane Database Syst Rev. 2014;12:CD006254.

PMID:
17054287
11.

Interventions for preventing bone disease in kidney transplant recipients.

Palmer S, McGregor DO, Strippoli GF.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005015. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD005015.

PMID:
15846740
12.

Interventions for treating sexual dysfunction in patients with chronic kidney disease.

Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Saglimbene V, Ruospo M, Querques M, Jannini EA, Strippoli GF.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD007747. doi: 10.1002/14651858.CD007747.pub2. Review.

PMID:
21154382
13.

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.

Avenell A, Gillespie WJ, Gillespie LD, O'Connell D.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000227. doi: 10.1002/14651858.CD000227.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD000227.

PMID:
19370554
14.

Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.

Palmer SC, Teixeira-Pinto A, Saglimbene V, Craig JC, Macaskill P, Tonelli M, de Berardis G, Ruospo M, Strippoli GF.

Am J Kidney Dis. 2015 Dec;66(6):962-71. doi: 10.1053/j.ajkd.2015.03.036. Epub 2015 May 21. Review.

15.

Parenteral versus oral iron therapy for adults and children with chronic kidney disease.

Albaramki J, Hodson EM, Craig JC, Webster AC.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD007857. doi: 10.1002/14651858.CD007857.pub2. Review.

PMID:
22258974
16.

Correction of chronic metabolic acidosis for chronic kidney disease patients.

Roderick P, Willis NS, Blakeley S, Jones C, Tomson C.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001890. Review.

PMID:
17253467
17.

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.

Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD000227. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD000227.

PMID:
16034849
18.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
19.

Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.

Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD.

Clin J Am Soc Nephrol. 2011 Jan;6(1):50-62. doi: 10.2215/CJN.03940510. Epub 2010 Sep 28. Review.

20.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900

Supplemental Content

Support Center